Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mingyou Dong has a total of 102 co-authors. Here are the top co-authors by number of shared publications:

  • Bixiao Wei

    Clinical Laboratory, Affiliated Souhwest Hospital of Youjiang Medical University for Nationalies

    4 shared publications
  • Fengdie Huang

    Clinical Laboratory, Baise People’s Hospital, Baise, China

    4 shared publications
  • Lusheng Liao

    Guangxi Engineering Research Center for Precise Genetic Testing of Long-Dwelling Nationalities, Baise, 533000, Guangxi, China

    3 shared publications
  • Run-Lei Du

    National Health Commission Key Laboratory of Birth Defect Research and Prevention, MOE Key Lab of Rare Pediatric Diseases, Hunan Provincial Key Laboratory of Basic and Clinical Pharmacological Research of Gastrointestinal Cancer, The Second Affiliated Hospital, School of Basic Medical Sciences, Hengyang Medical School, University of South China, Hengyang, China

    3 shared publications
  • Sheng Dou

    Clinical Laboratory, The Afffliated Hospital of Youjiang Medical University for Nationalities

    3 shared publications
  • Xin Zhang

    Guangxi Engineering Research Center for Precise Genetic Testing of Long-dwelling Nationalities, Youjiang Medical University for Nationalities, Baise, Guangxi, China

    3 shared publications

Latest Publications

  • Open Access

    Dendrobium officinale polysaccharides ameliorate radiation-induced premature ovarian insufficiency through coordinated modulation involving the gut microbiota-PI3K/AKT-glycolysis axis

    by Bixiao Wei, Yanyun Huang, Xiaofang Huang, Jian Wang, Sheng Dou, Fei Yu, Liuyi Huang, Mingyou Dong, Junli Wang

    Radiotherapy-induced premature ovarian insufficiency (POI) remains a clinical challenge with limited preventative strategies. Dendrobium officinale polysaccharides (DOP) exhibit beneficial bioactivities, but their efficacy and mechanism against radiation-induced POI are unknown. In this study, a mouse model of POI was established by single-dose whole-body X-ray irradiation (5 Gy). Mice were pretreated with a partially purified DOP preparation (500 mg/kg/day) for 7 days prior to and 14 days post-irradiation. Ovarian function was assessed via estrous cyclicity, hormone assays, histomorphology, and follicle counting. Mechanisms were investigated through analysis of apoptosis (TUNEL, IHC, flow cytometry), PI3K/AKT signaling and glycolysis-related marker expression (qPCR, IF, Western blot), and gut microbiota (16S rRNA sequencing), with in vitro validation using irradiated human granulosa cells (KGN). DOP pretreatment significantly attenuated POI phenotypes, restoring estrous cyclicity, improving serum sex hormone profiles (increased E2 and AMH; decreased FSH and LH), and preserving ovarian/uterine morphology and follicle pool. Mechanistically, DOP inhibited ovarian granulosa cell apoptosis in vivo and in vitro , concomitant with reduced ROS levels. Immunofluorescence and qPCR analyses revealed that DOP modulated the PI3K/AKT pathway in growing follicles while suppressing its overactivation in primordial follicles, as evidenced by modulated expression and localization of FOXO3a and rps6 and increased phosphorylation of AKT, mTOR, FOXO3a, and rps6. Concurrently, DOP upregulated the expression of glycolysis-related markers including GLUT4, HK1, PKM2, and LDHA at both mRNA and protein levels. Furthermore, DOP restored gut microbiota diversity and composition altered by irradiation, increasing the abundance of beneficial taxa such as Muribaculum. Collectively, these findings suggest that DOP exerts a protective effect against radiation-induced POI through a multi-targeted mechanism involving anti-apoptosis, modulation of PI3K/AKT signaling and glycolysis-related marker expression in growing follicles, inhibition of primordial follicle overactivation, and remediation of gut dysbiosis. These findings position DOP as a promising natural candidate for improving ovarian injury-related parameters, warranting further investigation.

  • Open Access

    Potential of FGF2 and GIPR as immunological biomarkers and therapeutic targets in recurrent pregnancy loss

    by Liuyi Huang, Jian Wang, Hongmei Huang, Xiaoqin Huang, Limin Huang, Huitian Huang, Fengdie Huang, Yulan Wei, Mingyou Dong, Bixiao Wei

  • Open Access

    Metabolic Pathways and Molecular Regulatory Mechanisms of Nervonic Acid Biosynthesis in Malania oleifera

    by Qijiang Xu, Chengyu Jiang, Mingyou Dong, Lusheng Liao, Guangfu Pang, Zhiyong Xing, Siyue Qi, Bo Zhou

    Nervonic acid (NA, C24:1 Δ15) is a vital extra-long-chain monounsaturated fatty acid essential for neural development, myelin sheath formation, and neurological health. As the most abundant natural source of NA, Malania oleifera Chun & S.K.Lee has become a key model for studying NA biosynthesis and regulation. This review systematically summarizes the metabolic pathways of nervonic acid biosynthesis in M. oleifera, including plastidial de novo fatty acid synthesis, endoplasmic reticulum (ER)-based very-long-chain fatty acid elongation, and Δ15 desaturation. We focus on the catalytic mechanisms and rate-limiting roles of the elongase complex (KCS, KCR, HCD, ECR) and Δ15 desaturase. Additionally, we integrate recent multi-omics data to analyze key enzyme KCS gene families, their phylogenetic relationships, and syntenic distribution patterns. Furthermore, transcriptional regulatory networks (MYB, bZIP, WRI1, ABI3, FUS3) and epigenetic regulation underlying NA accumulation are also discussed. Finally, we highlight advances, challenges, and prospects in metabolic engineering and synthetic biology for sustainable NA production. This review provides a theoretical basis for the conservation, molecular breeding, and biotechnological utilization of M. oleifera.

  • Open Access

    AGPAT family members act as potential predictive biomarkers and therapeutic targets in cervical cancer

    by Nannan Gui, Hanyi Pan, Weijuan Lu, Guiqiong Pan, Xiaoyu Zhou, Yuzhen Chen, Mingyang Jin, Changyong Yang, Mingyou Dong, Yuexiu Liang

    Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) are the primary histological subtypes of cervical cancer. Although the AGPAT family of enzymes is implicated in various cancer types, the specific roles of its members in cervical cancer remain unclear. In the present study, we investigated the value of AGPAT1-5 as potential biomarkers and therapeutic targets in cervical cancer by assessing their impact on disease development and outcomes. AGPAT gene expression data and clinical information from 306 patients with CESC and three control subjects were collected from The Cancer Genome Atlas. Given the limited number of normal cervical samples in TCGA (n = 3), we utilized the GEPIA database to integrate GTEx normal cervical samples (n = 10) as controls for differential expression analysis. These data were analyzed for differential gene expression, gene-gene and protein-protein interactions, prognostic and diagnostic value, clinical correlations, functional enrichment, and various tumor-infiltrating immune cell types. Validation was performed using two independent Gene Expression Omnibus (GEO) datasets (GSE6791 and GSE63514). The study revealed that AGPAT4 mRNA expression was significantly downregulated in cervical cancer tissues compared to normal tissues in the GEPIA analysis, while AGPAT1, AGPAT2, AGPAT3, and AGPAT5 showed no significant differences. Validation in GEO datasets demonstrated that AGPAT1, AGPAT2, and AGPAT3 were consistently downregulated in tumor tissues, whereas AGPAT5 was upregulated, and AGPAT4 showed no significant change. High levels of AGPAT3 and AGPAT4 expression, in particular, were associated with a worse prognosis in CESC patients. Immune infiltration analysis restricted to CESC samples revealed that AGPAT3 expression was significantly correlated with multiple immune cell types, including positive correlations with Macrophages M1, T cells CD4 memory resting, and Monocytes. Furthermore, guided by functional enrichment analysis implicating immune-related pathways, we examined the correlation between AGPAT3 expression and key T cell regulatory molecules, including FOXP3, IL2RA, IKZF2, and CCR8, revealing significant positive associations. In vitro assays demonstrated that knocking out AGPAT3 expression significantly decreased the proliferation and migration of HeLa and C-33 A cervical cancer cell line. These results suggest that AGPAT3 could be a valuable biomarker and a promising therapeutic target in cervical cancer.

  • CKAP5: Unraveling Its Crucial Function in Liver Hepatocellular Carcinoma Progression and Prognosis

    by Lusheng Liao, Yawen Li, Bixiao Wei, Mei Fei, Fengdie Huang, Yuejiao Huang, Yuhong Hu, Shanshan Xiao, Mingyou Dong, Qinqin Long

    Liver hepatocellular carcinoma (LIHC) remains a leading cause of cancer-related mortality worldwide, with limited therapeutic options for advanced stages. Cytoskeleton-associated protein 5 (CKAP5), a key regulator of microtubule dynamics, has emerged as a potential oncogene in multiple cancers, yet its precise role and clinical relevance in LIHC pathogenesis and tumor immunity are not fully understood. We systematically evaluated CKAP5 expression patterns using multi-omics data from TCGA, GEO, and the Human Protein Atlas. Prognostic significance was assessed through Kaplan-Meier survival analysis, Cox regression, and ROC curves. The association between CKAP5 and the tumor immune microenvironment was investigated via immune cell infiltration analysis, immune checkpoint correlation, and single-cell RNA sequencing. Mechanistic insights were explored through gene set enrichment analysis (GSEA), transcription factor activity inference, and protein-protein interaction network construction. Functional validation was performed using CRISPR-Cas9-mediated CKAP5 knockdown in HepG2 cells, followed by comprehensive assays measuring proliferation, migration, and invasion capabilities. CKAP5 was significantly overexpressed in LIHC tissues at both mRNA and protein levels, and its elevated expression correlated strongly with advanced tumor stage, poor differentiation, and unfavorable patient survival. CKAP5 expression was associated with distinct immune cell infiltration patterns and positively correlated with key immune checkpoint molecules (PD1, PDL1, and CTLA4). Bioinformatic analyses further revealed a potential mechanistic link between CKAP5 and immunosuppressive signaling pathways, including JAK-STAT and NF-κB. Functional studies demonstrated that CKAP5 depletion markedly suppressed LIHC cell proliferation, colony formation, migration, and invasion. Our integrated analysis establishes CKAP5 as a critical promoter of LIHC progression and a modulator of the tumor immune microenvironment. These findings nominate CKAP5 as a promising prognostic biomarker and a potential therapeutic target, providing new insights into LIHC pathogenesis and future treatment strategies.

  • Open Access

    Expression characteristics, prognostic value, and immune-related analysis of PPP2R1A in lung adenocarcinoma

    by Shanshan Xiao, Yuhong Hu, Yawen Li, Xin Zhang, Zijun Xiao, Mingyou Dong, Lusheng Liao

    Introduction: Lung adenocarcinoma (LUAD) is a major subtype of lung cancer with poor prognosis. The protein phosphatase 2 regulatory subunit A alpha (PPP2R1A) plays complex roles in tumorigenesis, but its function and clinical significance in LUAD remain unclear. Methods: We analyzed PPP2R1A expression across cancers using the Xiantao Academic Online tool and TCGA data. Diagnostic potential was evaluated via ROC curve analysis. Prognostic value was assessed using Kaplan-Meier survival and Cox regression analyses. Protein-protein interaction networks and functional enrichment analyses were conducted to explore molecular mechanisms. Immune infiltration patterns were investigated using TIMER2.0. Experimental validation was performed through CRISPR/Cas9-mediated knockdown in A549 cells, followed by functional assays including CCK-8, clonogenic, wound healing, and Transwell assays. Results: PPP2R1A was significantly upregulated in LUAD tissues compared to normal controls (P < 0.05). It demonstrated modest diagnostic value with an AUC of 0.593. High PPP2R1A expression was associated with poor progression-free survival (FP) and overall survival (OS), particularly in early-stage disease. PPP2R1A expression correlated with advanced N stage and tumor stage. Functional enrichment analysis revealed involvement in protein dephosphorylation, cell cycle regulation, and metabolic pathways. Immune infiltration analysis showed significant correlations with macrophage and CD4+ T cell infiltration. Experimental validation confirmed that PPP2R1A knockdown significantly inhibited LUAD cell proliferation, migration, and invasion (P < 0.01). Discussion: PPP2R1A is overexpressed in LUAD and associated with poor prognosis, potentially serving as an oncogene by regulating key signaling pathways and immune microenvironment. Its knockdown suppresses malignant phenotypes, highlighting its potential as both a prognostic biomarker and therapeutic target in LUAD.


  • Open Access

    The role of SLC2A1 in lung adenocarcinoma: From tumorigenesis to patient survival

    by Zijun Xiao, Qinqin Long, Jiaxing Liao, Fengdie Huang, Lusheng Liao, Mingyou Dong

    Objective: Our study aimed at systematically exploring the effect of the solute carrier family 2 Member (SLC2A) genes family on the prognosis and immune landscape of lung adenocarcinoma (LUAD) patients. Furthermore, we sought to determine the SLC2A1 function in LUAD initiation and progression through in vivo and in vitro experiments. Methods: A comprehensive bioinformatics analysis was conducted utilizing online tools and software, including R packages, Gene Set Cancer Analysis (GSCA), cBio Cancer Genomics Portal (cBioPortal), GeneMANIA, STRING, and Xiantao Academic Online databases, to assess the functional implications of the SLC2A gene family in LUAD. Concurrently, in vivo and in vitro experiments at the cellular and animal levels were conducted to ascertain the effects of SLC2A1 gene knockout on LUAD development. Results: Compared to normal tissues, the SLC2A gene family exhibited significant upregulation across various tumor types, including LUAD, with a low mutation frequency in LUAD. SLC2A1 and SLC2A7 emerged as prognostic biomarkers for LUAD. The receiver operating characteristic (ROC) curve analysis revealed high diagnostic accuracy of SLC2A1 for LUAD. A significant negative correlation was observed between SLC2A1 expression and DNA methylation levels in LUAD, and the gene was closely linked to cellular processes such as cell nuclear division, DNA replication, and metabolism. Moreover, SLC2A1 expression was strongly linked to immune infiltration and regulation across different tumor types. In vitro and in vivo experiments showcased that SLC2A1 inhibition significantly hampered LUAD A549 cell proliferation, migration, and invasion capabilities, as well as tumor growth in nude mice. Finally, our study demonstrated that reduced SLC2A1 expression influenced the expression of molecules within the P53 signaling pathway. Conclusions: This study elucidates the functional role of the SLC2A gene family in the pathogenesis of LUAD, underscoring the importance of SLC2A1 in LUAD diagnosis, prognosis, and immune response, and presenting SLC2A1 as a promising biomarker for LUAD.


  • Open Access

    USP19 deficiency enhances T-cell-mediated antitumor immunity by promoting PD-L1 degradation in colorectal cancer

    by Feng Shi, Guang-Jing Li, Yi Liu, Hai-Meng Zhou, Yue Zhang, Si-Yi Wei, Bo-Jun Zan, Meng Gao, Fei-Shan Chen, Bo-Xin Li, et al.


  • The NLRP3 activation-related signature predicts the diagnosis and indicates immune characteristics in endometriosis

    by Weihua Nong, Huimei Wei, Sheng Dou, Liqiao He, Luping Lin, Donglin Lu, Bixiao Wei, Shun Zhang, Peng Huo, Mingyou Dong


  • Exploring the potential biological function of GRK2 in colorectal cancer

    by Meng Gao, Xinyi Liang, Mengqi Fan, Yutong Wu, Ming-You Dong, Run-Lei Du

    Background Colorectal cancer (CRC) is a malignant tumor of the gastrointestinal tract with high morbidity and mortality. There is growing evidence that GRK2 plays a key role in the development and progression of several human cancers. However, the role and potential mechanisms of GRK2 in colon cancer (COAD) are unclear. Methods The expression data of GRK2 was downloaded from The Cancer Genome Atlas database (TCGA). Variation in GRK2 was explored based on the cBioPortal database. The TIMER and TISCH2 databases were used to analyse the relationship between GRK2 expression and tumor immune microenvironment (TME). A log-rank test was used to compare the prognosis of high and low expression of GRK2 groups. Detecting the effect of GRK2 on cell cycle and apoptosis induced by 5-Fluorouracil (5-FU) through the flow cytometry and detection of apoptosis-related molecules by Western blot. Results We demonstrated that GRK2 has a potential oncogenic role. GRK2 expression was upregulated in COAD, which predicted poorer overall survival in COAD patients. The cellular assays showed that GRK2 plays a role in the growth and proliferation of colon cancer cells, also the expression of GRK2 have relationship with the sensitivity of 5-FU and cell cycle progression. Conclusions Our results suggest that high GRK2 expression is closely associated with the development of tumor and affects the 5-FU sensitivity.